0.00Open0.00Pre Close0 Volume0 Open Interest34.00Strike Price0.00Turnover0.00%IV-25.32%PremiumJan 3, 2025Expiry Date6.87Intrinsic Value100Multiplier-4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma--Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Pfizer Stock Discussion
The stock is trading above 120 EMA. The trend is likely to be up. Next resistance is 27.56. Once it breaks the resistance, next hit point will be 27.70. The need for new vaccines for H5N1 and rising covid cases in USA are propelling up the stock. Time for Pfizer to shine this year.
is there anything that ring the bell ?
The chart looks good with RSI turning up and stock becoming bullish. Next resistance is 27.56. Once it breaks the resistance, next hit point will be 27.70.
Moderna stock jumped early Tuesday after the first bird flu death was reported in the U.S.
Shares were up 3.8% to $44.23 in premarket trading, after initially rising as much as 6%. Futures tracking the benchmark S&P 500 index traded largely flat.
Moderna is one of a few drugmakers currently developing a vaccine for the H5N1 bird flu, which is spreading rapidly through farms and wild animals in North America.
As of Jan. 6, there have been 66 confirmed human cases of H5N1 bird ...
The stock has broken the 26.83 resistance. Next hit point will be 27.15.
Malaysia saw 327 cases of human metapneumovirus (HMPV) infections in 2024, a 45 per cent rise from the 225 cases in 2023.
The Health Ministry said on Jan 4 that HMPV – a respiratory tract infection caused by a virus in the Pneumoviridae family – is not a new disease.
Those with HMPV typically experience symptoms similar to those of a common cold, but in more severe cases the symptoms can progress to bronchitis or pneumonia.
Malaysia recorded 327 HMPV cases in 2024; Health Ministry urges public to remain vigilant | The Straits Times
No comment yet